» Articles » PMID: 22201874

Development and Deployment of Antigen Arrays for Investigation of B-cell Fine Specificity in Autoimmune Disease

Overview
Specialty Biology
Date 2011 Dec 29
PMID 22201874
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Recent developments in proteomic technologies have enabled the high-throughput, multiplex measurement of large panels of antibodies in biological fluids of patients with immune-driven diseases. Antigen microarrays are increasingly being used to delineate the natural history of autoantibody formation and epitope spread, and thus gain insight into the pathogenesis of autoimmune diseases, as well as into host immunity and its shortcomings. Characterization of autoimmunity that precedes the onset of clinically apparent disease has the potential to guide disease prevention using either conventional immunosupression or novel, antigen-specific tolerizing therapies. In addition, autoantibody profiling has the potential to identify molecular subtypes of a disease, which could allow for prediction of disease outcomes such as severity, tissue damage, and response to therapy.

Citing Articles

Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

Sokolove J, Wagner C, Lahey L, Sayles H, Duryee M, Reimold A Rheumatology (Oxford). 2016; 55(11):1969-1977.

PMID: 27477806 PMC: 5088624. DOI: 10.1093/rheumatology/kew285.


Elevated IgA Plasmablast Levels in Subjects at Risk of Developing Rheumatoid Arthritis.

Kinslow J, Blum L, Deane K, Demoruelle M, Okamoto Y, Parish M Arthritis Rheumatol. 2016; 68(10):2372-83.

PMID: 27273876 PMC: 5042824. DOI: 10.1002/art.39771.


Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Crowley J, Strle K, Drouin E, Pianta A, Arvikar S, Wang Q J Autoimmun. 2016; 69:24-37.

PMID: 26922382 PMC: 4826816. DOI: 10.1016/j.jaut.2016.02.005.


Decade in review-technology: Technological advances transforming rheumatology.

Robinson W, Mao R Nat Rev Rheumatol. 2015; 11(11):626-8.

PMID: 26439404 PMC: 4769868. DOI: 10.1038/nrrheum.2015.137.


Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis.

Pianta A, Drouin E, Crowley J, Arvikar S, Strle K, Costello C Clin Immunol. 2015; 160(2):336-41.

PMID: 26187145 PMC: 4582008. DOI: 10.1016/j.clim.2015.07.005.


References
1.
Auger I, Balandraud N, Rak J, Lambert N, Martin M, Roudier J . New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA. Ann Rheum Dis. 2008; 68(4):591-4. DOI: 10.1136/ard.2008.096917. View

2.
Li Q, Zhou J, Wandstrat A, Carr-Johnson F, Branch V, Karp D . Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes. Clin Exp Immunol. 2006; 147(1):60-70. PMC: 1810453. DOI: 10.1111/j.1365-2249.2006.03251.x. View

3.
Hu L, Xu G . Applications and trends in electrochemiluminescence. Chem Soc Rev. 2010; 39(8):3275-304. DOI: 10.1039/b923679c. View

4.
Haab B, Dunham M, Brown P . Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2001; 2(2):RESEARCH0004. PMC: 25774. DOI: 10.1186/gb-2001-2-2-research0004. View

5.
Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S . Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum. 2010; 62(2):383-91. DOI: 10.1002/art.27186. View